While BRG1 and BRM loss have been studied in detail within cell lines (microarray studies) and in association with certain genes, the overall net effect of BRG1/BRM loss on gene expression in hundreds of molecularly heterogeneous tumor cells is not yet known. The gene discussed is SMARCA2; the disease is neoplasm.